Prevalence and Sequelae of Computer Vision Syndrome in Egyptian Universities

Computer Vision Syndrome Clinical Trial

Official title:

Visual, Ocular Surface and Extraocular Diagnostic Criteria for Prevalence of Computer Vision Syndrome: A Cross-sectional Smart-survey Based Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05187221
• Other study ID #: Soh-Med-21-12-31
• Status: Completed
• Start date: December 30, 2021
• Est. completion date: September 1, 2022

Study information

• Verified date: May 2024
• Source: Sohag University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

CVS-F4 questionnaire will be used as an instrument to survey CVS prevalence and severity among medical students

Description:

CVS-F4 (30 questions) will be an online survey via the SurveyMonkey Company. We will collect the responses and analyze the results. Informed consent will be obtained from the participants as an item within the survey itself that he/she agrees to use his/her data in this research work. The questionnaire includes questions regarding potential ocular, extra-ocular, musclo-skeletal and neuro-psychatric complains caused by CVS. Complete statistical analysis of the survey data will be done using univariate and multivariate logistic and linear regression analysis. The CVS diagnosis will be based on the 5 diagnostic criteria (5DC) to create a new short self-assessment questionnaire for accurate prevalence of CVS.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 8085
• Est. completion date: September 1, 2022
• Est. primary completion date: May 20, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

• university students

• university staff members

Exclusion Criteria:

• ocular surgery

• amblyopia

• anisometropia

• strabismus

• systemic disease

Related Conditions & MeSH terms

• Computer Vision Syndrome
• Syndrome

Intervention

Behavioral:
• CVS Group
CVS-F4 will be an online survey via the SurveyMonkey Company. The participants will report their potential CVS complains and associated screen factors as screen-time, screen-size, screen-resolution and other factors. We will collect the responses and analyse the results. Informed consent will be obtained from the participants as an item within the survey itself that he/she agrees to use his/her data in this research work. This group will contain participants with CVS complains.

Locations

Country	Name	City	State
Egypt	Faculty of medicine	Sohag
Egypt	Faculty of medicine	Sohag,	Sohag

Sponsors (1)

Lead Sponsor	Collaborator
Sohag University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of participants suffering from CVS	will be reported in form of percentage (%) of students with CVS	3 months
Primary	Rate of CVS symptoms-attacks	The results will be presented as annual percentage	3 months